Understanding how S. aureus bacteria evade the immune system during infections

Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of Infection

NIH-funded research Montana State University - Bozeman · NIH-10849639

This study is looking at how a common bacteria called Staphylococcus aureus manages to escape our immune system's defenses, specifically focusing on a part of the bacteria that helps it survive against immune cells. By understanding this, the researchers hope to find new ways to create vaccines and treatments that can better fight infections, especially those that are hard to treat. This could lead to better options for patients dealing with serious infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMontana State University - Bozeman NIH-funded
Lab location1 site (Bozeman, United States)
Project IDNIH-10849639 on NIH RePORTER

What this research studies

This research investigates the interactions between Staphylococcus aureus (S. aureus) and neutrophils, a type of immune cell, to understand how the bacteria evade the body's defenses. The study focuses on a specific gene regulatory system called SaeR/S, which is crucial for S. aureus to resist being killed by neutrophils. By examining these interactions, the research aims to uncover new strategies for developing vaccines and therapies that can effectively treat bacterial infections, particularly those caused by drug-resistant strains. Patients may benefit from insights that could lead to improved treatment options for common and severe infections.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from S. aureus infections, particularly those with recurrent or severe cases.

Not a fit: Patients with infections caused by bacteria other than S. aureus may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel vaccines and therapies that effectively combat S. aureus infections.

How similar studies have performed: Previous research has shown promise in understanding bacterial resistance mechanisms, but this specific approach focusing on the SaeR/S system is relatively novel.

Where this research is happening

Bozeman, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions bacteria infectionbacterial diseaseBacterial Infections
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.